Department of Psychology, University of California, Los Angeles.
Department of Psychology, Southern Methodist University.
J Consult Clin Psychol. 2023 Jun;91(6):350-366. doi: 10.1037/ccp0000805. Epub 2023 Mar 9.
Determine whether a novel psychosocial treatment for positive affect improves clinical status and reward sensitivity more than a form of cognitive behavioral therapy that targets negative affect and whether improvements in reward sensitivity correlate with improvements in clinical status.
In this assessor-blinded, parallel-group, multisite, two-arm randomized controlled clinical superiority trial, 85 treatment-seeking adults with severely low positive affect, moderate-to-severe depression or anxiety, and functional impairment received 15 weekly individual therapy sessions of positive affect treatment (PAT) or negative affect treatment (NAT). Clinical status measures were self-reported positive affect, interviewer-rated anhedonia, and self-reported depression and anxiety. Target measures were eleven physiological, behavioral, cognitive, and self-report measures of reward anticipation-motivation, response to reward attainment, and reward learning. All analyses were intent-to-treat.
Compared to NAT, individuals receiving PAT achieved superior improvements in the multivariate clinical status measures at posttreatment, = .37, 95% CI [.15, .59], (109) = 3.34, = .001, = .004, = .64. Compared to NAT, individuals receiving PAT also achieved higher multivariate reward anticipation-motivation, = .21, 95% CI [.05, .37], (268) = 2.61, = .010, = .020, = .32, and higher multivariate response to reward attainment, = .24, 95% CI [.02, .45], (266) = 2.17, = .031, = .041, = .25, at posttreatment. Measures of reward learning did not differ between the two groups. Improvements in reward anticipation-motivation and in response to reward attainment correlated with improvements in the clinical status measures.
Targeting positive affect results in superior improvements in clinical status and reward sensitivity than targeting negative affect. This is the first demonstration of differential target engagement across two psychological interventions for anxious or depressed individuals with low positive affect. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
确定一种新的针对积极情绪的心理社会治疗是否比针对消极情绪的认知行为疗法更能改善临床状况和奖励敏感性,以及奖励敏感性的改善是否与临床状况的改善相关。
在这项评估员盲法、平行组、多地点、两臂随机对照临床试验中,85 名寻求治疗的积极情绪严重低下、中重度抑郁或焦虑且有功能障碍的成年人接受了 15 周的每周一次个体治疗,分别接受积极情绪治疗(PAT)或消极情绪治疗(NAT)。临床状况评估指标包括自我报告的积极情绪、访谈者评定的快感缺失以及自我报告的抑郁和焦虑。目标评估指标包括 11 项生理、行为、认知和自我报告的奖励预期-动机、奖励获得反应和奖励学习的指标。所有分析均采用意向治疗。
与 NAT 相比,接受 PAT 的个体在治疗后,多维临床状况评估指标得到了更好的改善, =.37,95%置信区间[.15,.59],(109)=3.34, =.001, =.004, =.64。与 NAT 相比,接受 PAT 的个体在治疗后也表现出更高的多维奖励预期-动机, =.21,95%置信区间[.05,.37],(268)=2.61, =.010, =.020, =.32,以及更高的多维奖励获得反应, =.24,95%置信区间[.02,.45],(266)=2.17, =.031, =.041, =.25,在治疗后。两组之间的奖励学习指标没有差异。奖励预期-动机和奖励获得反应的改善与临床状况评估指标的改善相关。
针对积极情绪的治疗比针对消极情绪的治疗能更显著地改善临床状况和奖励敏感性。这是首次证明针对积极情绪低下的焦虑或抑郁个体的两种心理干预措施在目标上存在差异。